About
Digital Diagnostics, formerly known as IDx, is an innovative company focused on AI diagnostics for medical image analysis, particularly in eye diseases. Founded on research from the University of Iowa and led by Dr. Michael Abramoff, the company aims to enhance healthcare quality and accessibility through its advanced technology. The flagship product, LumineticsCore®, is the first FDA-cleared autonomous AI diagnostic system for detecting diabetic retinopathy, a major cause of blindness in adults with diabetes. This system allows primary care providers to conduct specialty-level diagnostics without needing a specialist's interpretation. Digital Diagnostics has received FDA "Breakthrough Device" designation for this product, which is designed to be used in various healthcare settings, especially in underserved areas. In addition to diabetic retinopathy, Digital Diagnostics is developing AI algorithms for other eye diseases and exploring applications for conditions like Alzheimer's disease and cardiovascular issues. The company partners with organizations like IBM Watson Health to expand its reach and impact in the healthcare sector.
Technologies
Keywords
Company Information
-
Employees 23
-
Founded 2010
-
Total Funding $42599986
Location
2300 Oakdale Boulevard, Coralville, Iowa, United States, 52241
